Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-16 Sale |
2023-03-20 6:43 pm |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
4,257 | $1.979 | $8,425 | 58,433 (Direct) |
View |
| 2022-07-20 Sale |
2022-07-21 4:11 pm |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
7,463 | $1.422 | $10,612 | 62,690 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-03-31 7:43 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Peterson Amy C. EVP Prod Dev & Med Aff & CMO |
159,383 | $0 | 506,472 (Direct) |
View |
| 2025-02-26 Option Award |
2025-02-28 8:34 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Peterson Amy C. EVP Prod Dev & Med Aff & CMO |
52,192 | $0 | 347,089 (Direct) |
View |
| 2024-11-15 Tax Withholding |
2024-11-19 8:02 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Peterson Amy C. EVP Prod Dev & Med Aff & CMO |
27,224 | $35.05 | 294,897 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 6:59 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Peterson Amy C. EVP Prod Dev & Med Aff & CMO |
82,121 | $0 | 322,121 (Direct) |
View |
| 2023-08-24 Option Award |
2023-08-25 7:40 pm |
2024-08-24 2030-08-23 |
EXELIXIS INC. | EXEL | Peterson Amy C. EVP Prod Dev & Med Aff & CMO |
400,000 | $0 | 400,000 (Direct) |
View |
| 2022-07-19 Option Award |
2022-07-21 4:11 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
20,000 | $0 | 62,690 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 4:53 pm |
N/A 2032-02-01 |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
240,000 | $0 | 246,421 (Direct) |
View |
| 2021-10-24 Option Award |
2021-10-26 4:26 pm |
N/A 2031-10-23 |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2021-05-31 Option Award |
2021-06-08 1:07 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
3,320 | $6.086 | 6,421 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:07 pm |
N/A 2031-02-25 |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-07 4:59 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer |
3,101 | $6.392 | 3,101 (Direct) |
View |